Revenue from Contracts with Customers (Tables)

6 Months Ended

Jun. 26, 2020

Disaggregation of Revenue [Line Items]

Sales Reserves Rollforward

The following table reflects activity in the Company's sales reserve accounts:

	Rebates and Chargebacks		Product Returns		Other Sales Deductions		Total
Balance as of December 28, 2018	$	354.3	$	34.0	$	17.1	$	405.4
Provisions	1,214.3		11.7		34.7		1,260.7
Payments or credits	(1,240.2)		(15.6)		(35.9)		(1,291.7)
Balance as of June 28, 2019	$	328.4	$	30.1	$	15.9	$	374.4
Balance as of December 27, 2019	$	295.8	$	28.4	$	13.2	$	337.4
Provisions (1)	947.5		13.3		29.2		990.0
Provision for Medicaid lawsuit (Note 11) (2)	534.4		—		—		534.4
Payments or credits	(982.0)		(15.4)		(31.7)		(1,029.1)
Balance as of June 26, 2020	$	795.7	$	26.3	$	10.7	$	832.7

(1)Rebates and Chargebacks include the prospective change to the Medicaid rebate calculation of $8.6 million for the period from June 15, 2020 to June 26, 2020, of which $6.8 million represents the channel impact. See Note 11 for further detail on the status of the Medicaid lawsuit.

(2)Excludes the $105.3 million that is reflected as a component of operating expenses as it represents a pre-acquisition contingency related to the portion of the liability that arose from sales of Acthar Gel prior to the Company’s acquisition of Questcor Pharmaceuticals Inc. ("Questcor") in August 2014. See Note 11 for further detail on the status of the Medicaid lawsuit.

Disaggregation of Revenue

Product sales transferred to customers at a point in time and over time were as follows:

	Three Months Ended				Six Months Ended
	June 26, 2020		June 28, 2019		June 26, 2020		June 28, 2019
Product sales transferred at a point in time	77.7	%	82.9	%	78.1	%	81.8	%
Product sales transferred over time	22.3		17.1		21.9		18.2

The associated royalty revenue recognized was as follows:

	Three Months Ended				Six Months Ended
	June 26, 2020		June 28, 2019		June 26, 2020		June 28, 2019
Royalty revenue	$	16.3	$	19.4	$	31.9	$	36.8

Contract with Customer, Timing of Satisfaction of Performance Obligation and Payment

The following table includes estimated revenue from contracts extending greater than one year for certain of the Company's hospital products that are expected to be recognized in the future related to performance obligations that were unsatisfied or partially unsatisfied as of June 26, 2020:

Remainder of Fiscal 2020	$	97.9
Fiscal 2021	102.7
Fiscal 2022	37.7
Fiscal 2023	8.1
Thereafter	0.3

Contract with Customer, Asset and Liability

The following table reflects the balance of the Company's contract liabilities at the end of each period:

	June 26, 2020		December 27, 2019
Accrued and other current liabilities	$	3.4	$	5.6
Other liabilities	0.4		0.6
Contract liabilities	$	3.8	$	6.2